Earnings Feed
Start Free
Home/Filings/4/0001209191-17-030990
4//SEC Filing

AtriCure, Inc. 4

Accession 0001209191-17-030990

$ATRCCIK 0001323885operating
View on SEC.govCompany Profile

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:51 PM ET

Size

12.1 KB

Accession

0001209191-17-030990

Insider Transaction Report

Form 4
Period: 2017-05-05
AtriCure, Inc.ATRC
Hooven Michael D
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2017-05-05$9.50/sh+10,000$95,000→ 67,049 total
  • Sale

    Common Stock

    2017-05-05$22.08/sh−10,000$220,800→ 57,049 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-05-05−10,000→ 0 total
    Exercise: $9.50From: 2008-06-20Exp: 2017-06-20→ Common Stock (10,000 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    234,211

  • Common Stock

    (indirect: By Trust)
    234,211

  • Common Stock

    (indirect: By Trust)
    18,421
Footnotes (7)
  • [F1]These shares were sold pursuant to a 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $22.00 to $22.32 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]These shares were exercised pursuant to a 10b5-1 trading plan.
  • [F4]Held by Michael D. Hooven 2004 Trust FBO Michael. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
  • [F5]Held by Michael D. Hooven 2004 Trust FBO Susan. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
  • [F6]Held by Susan Spies 2004 Children's Trust. These shares are held in trust for the benefit of the Reporting Person's son. Reporting Person is the trustee of that trust. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
  • [F7]These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.

Documents

1 file

Issuer

AtriCure, Inc.

CIK 0001323885

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001323885

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:51 PM ET
Size
12.1 KB
View on SEC.gov